DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Lynch CJ, Cawte AD, Millar CM, Rueda D, Lane DA.
A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.
PLoS One 2017;
12 (11) e0188405
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.